| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cell-matrix adhesion mediator activity | 2.14e-06 | 9 | 60 | 3 | GO:0098634 | |
| GeneOntologyMolecularFunction | integrin binding | 1.41e-05 | 175 | 60 | 6 | GO:0005178 | |
| GeneOntologyMolecularFunction | C-X3-C chemokine binding | 8.83e-05 | 5 | 60 | 2 | GO:0019960 | |
| GeneOntologyMolecularFunction | integrin binding involved in cell-matrix adhesion | 8.83e-05 | 5 | 60 | 2 | GO:0098640 | |
| GeneOntologyMolecularFunction | collagen binding involved in cell-matrix adhesion | 8.83e-05 | 5 | 60 | 2 | GO:0098639 | |
| GeneOntologyMolecularFunction | collagen binding | 1.03e-04 | 81 | 60 | 4 | GO:0005518 | |
| GeneOntologyMolecularFunction | collagen receptor activity | 1.32e-04 | 6 | 60 | 2 | GO:0038064 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | LHCGR NPFFR2 DDR1 AMHR2 LPAR3 GPR19 ANTXR2 OSCAR TMIGD3 TAS2R19 IL3RA CRLF2 | 5.97e-04 | 1353 | 60 | 12 | GO:0004888 |
| GeneOntologyMolecularFunction | cytokine binding | 1.27e-03 | 157 | 60 | 4 | GO:0019955 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 1.32e-03 | 18 | 60 | 2 | GO:0008381 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 1.38e-03 | 73 | 60 | 3 | GO:0050840 | |
| GeneOntologyMolecularFunction | cell adhesion mediator activity | 1.55e-03 | 76 | 60 | 3 | GO:0098631 | |
| GeneOntologyMolecularFunction | protein-hormone receptor activity | 1.97e-03 | 22 | 60 | 2 | GO:0016500 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 4.16e-03 | 32 | 60 | 2 | GO:0015106 | |
| GeneOntologyMolecularFunction | chemokine binding | 4.42e-03 | 33 | 60 | 2 | GO:0019956 | |
| GeneOntologyMolecularFunction | laminin binding | 4.68e-03 | 34 | 60 | 2 | GO:0043236 | |
| GeneOntologyMolecularFunction | fibronectin binding | 5.82e-03 | 38 | 60 | 2 | GO:0001968 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 6.32e-03 | 125 | 60 | 3 | GO:0015108 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 2.15e-06 | 124 | 63 | 6 | GO:0007229 | |
| GeneOntologyBiologicalProcess | cell adhesion mediated by integrin | 8.59e-06 | 91 | 63 | 5 | GO:0033627 | |
| GeneOntologyBiologicalProcess | negative regulation of vasoconstriction | 2.14e-05 | 18 | 63 | 3 | GO:0045906 | |
| GeneOntologyBiologicalProcess | steroid biosynthetic process | 4.23e-05 | 209 | 63 | 6 | GO:0006694 | |
| GeneOntologyBiologicalProcess | regulation of steroid hormone biosynthetic process | 5.25e-05 | 24 | 63 | 3 | GO:0090030 | |
| GeneOntologyBiologicalProcess | leukocyte migration | 6.43e-05 | 449 | 63 | 8 | GO:0050900 | |
| GeneOntologyBiologicalProcess | positive regulation of enamel mineralization | 1.37e-04 | 6 | 63 | 2 | GO:0070175 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 1.46e-04 | 376 | 63 | 7 | GO:0008202 | |
| GeneOntologyBiologicalProcess | lipid biosynthetic process | LHCGR MBTPS1 GPAA1 CLCN2 SGMS1 CYP17A1 CFTR AGPAT1 SDR42E1 SMPD1 | 1.65e-04 | 813 | 63 | 10 | GO:0008610 |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 1.73e-04 | 270 | 63 | 6 | GO:0007160 | |
| GeneOntologyBiologicalProcess | regulation of hormone biosynthetic process | 1.80e-04 | 36 | 63 | 3 | GO:0046885 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 2.36e-04 | 286 | 63 | 6 | GO:0042445 | |
| GeneOntologyBiologicalProcess | alcohol metabolic process | 2.55e-04 | 412 | 63 | 7 | GO:0006066 | |
| GeneOntologyBiologicalProcess | regulation of steroid biosynthetic process | 3.11e-04 | 106 | 63 | 4 | GO:0050810 | |
| GeneOntologyBiologicalProcess | positive regulation of mast cell activation | 3.26e-04 | 9 | 63 | 2 | GO:0033005 | |
| GeneOntologyBiologicalProcess | positive regulation of tooth mineralization | 3.26e-04 | 9 | 63 | 2 | GO:0070172 | |
| GeneOntologyBiologicalProcess | regulation of tube diameter | 3.80e-04 | 202 | 63 | 5 | GO:0035296 | |
| GeneOntologyBiologicalProcess | blood vessel diameter maintenance | 3.80e-04 | 202 | 63 | 5 | GO:0097746 | |
| GeneOntologyBiologicalProcess | regulation of tube size | 3.89e-04 | 203 | 63 | 5 | GO:0035150 | |
| GeneOntologyBiologicalProcess | regulation of enamel mineralization | 4.07e-04 | 10 | 63 | 2 | GO:0070173 | |
| GeneOntologyCellularComponent | cell surface | TMC1 ANTXR2 SLAMF9 IFITM3 CFTR OSCAR RAET1E ITGA1 ITGA2B ITGA4 ITGA9 LY75 ADAM10 ITGB1 IL3RA CRLF2 CYP2W1 | 2.45e-08 | 1111 | 64 | 17 | GO:0009986 |
| GeneOntologyCellularComponent | integrin complex | 4.33e-08 | 32 | 64 | 5 | GO:0008305 | |
| GeneOntologyCellularComponent | external side of plasma membrane | TMC1 ANTXR2 SLAMF9 RAET1E ITGA1 ITGA2B ITGA4 ITGA9 LY75 ITGB1 IL3RA CRLF2 | 4.91e-08 | 519 | 64 | 12 | GO:0009897 |
| GeneOntologyCellularComponent | receptor complex | TRAV12-1 LHCGR DDR1 AMHR2 ITGA1 ITGA2B ITGA4 ITGA9 ITGB1 IL3RA CRLF2 TRAV21 | 1.67e-07 | 581 | 64 | 12 | GO:0043235 |
| GeneOntologyCellularComponent | side of membrane | NPHS2 TMC1 ANTXR2 SLAMF9 MDGA2 RAET1E ITGA1 ITGA2B ITGA4 ITGA9 LY75 ITGB1 IL3RA CRLF2 | 3.11e-07 | 875 | 64 | 14 | GO:0098552 |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 1.01e-06 | 59 | 64 | 5 | GO:0098636 | |
| GeneOntologyCellularComponent | integrin alpha1-beta1 complex | 9.23e-06 | 2 | 64 | 2 | GO:0034665 | |
| GeneOntologyCellularComponent | integrin alpha4-beta1 complex | 2.76e-05 | 3 | 64 | 2 | GO:0034668 | |
| GeneOntologyCellularComponent | integrin alpha9-beta1 complex | 2.76e-05 | 3 | 64 | 2 | GO:0034679 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 9.51e-05 | 350 | 64 | 7 | GO:0098802 | |
| GeneOntologyCellularComponent | basal part of cell | 1.04e-03 | 378 | 64 | 6 | GO:0045178 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | MBTPS1 YIF1A ANTXR2 GPAA1 SGMS1 SMIM14 CYP17A1 CFTR AGPAT1 RETSAT CYP2W1 | 1.75e-03 | 1293 | 64 | 11 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | MBTPS1 YIF1A ANTXR2 GPAA1 SGMS1 SMIM14 CYP17A1 CFTR AGPAT1 RETSAT CYP2W1 | 1.81e-03 | 1299 | 64 | 11 | GO:0098827 |
| GeneOntologyCellularComponent | focal adhesion | 2.03e-03 | 431 | 64 | 6 | GO:0005925 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | MBTPS1 YIF1A ANTXR2 GPAA1 SGMS1 SMIM14 CYP17A1 CFTR AGPAT1 RETSAT CYP2W1 | 2.14e-03 | 1327 | 64 | 11 | GO:0042175 |
| GeneOntologyCellularComponent | cell-substrate junction | 2.33e-03 | 443 | 64 | 6 | GO:0030055 | |
| GeneOntologyCellularComponent | basal plasma membrane | 4.56e-03 | 354 | 64 | 5 | GO:0009925 | |
| GeneOntologyCellularComponent | membrane protein complex | TRAV12-1 GPAA1 CLCN2 CFTR ITGA1 ITGA2B ITGA4 ITGA9 ADAM10 ITGB1 TRAV21 | 5.42e-03 | 1498 | 64 | 11 | GO:0098796 |
| Domain | Integrin_dom | 1.34e-08 | 25 | 59 | 5 | IPR032695 | |
| Domain | Integrin_alpha_C_CS | 1.59e-07 | 16 | 59 | 4 | IPR018184 | |
| Domain | Integrin_alpha-2 | 2.66e-07 | 18 | 59 | 4 | IPR013649 | |
| Domain | Integrin_alpha2 | 2.66e-07 | 18 | 59 | 4 | PF08441 | |
| Domain | Integrin_alpha | 2.66e-07 | 18 | 59 | 4 | IPR000413 | |
| Domain | INTEGRIN_ALPHA | 2.66e-07 | 18 | 59 | 4 | PS00242 | |
| Domain | Int_alpha_beta-p | 3.36e-07 | 19 | 59 | 4 | IPR013519 | |
| Domain | Int_alpha | 3.36e-07 | 19 | 59 | 4 | SM00191 | |
| Domain | FG_GAP | 6.30e-07 | 22 | 59 | 4 | PS51470 | |
| Domain | FG-GAP | 9.10e-07 | 24 | 59 | 4 | PF01839 | |
| Domain | FG-GAP | 9.10e-07 | 24 | 59 | 4 | IPR013517 | |
| Domain | Integrin_alpha | 5.30e-04 | 11 | 59 | 2 | PF00357 | |
| Domain | CD225 | 7.48e-04 | 13 | 59 | 2 | PF04505 | |
| Domain | CD225/Dispanin_fam | 7.48e-04 | 13 | 59 | 2 | IPR007593 | |
| Domain | VWFA | 2.22e-03 | 82 | 59 | 3 | PS50234 | |
| Domain | VWA | 2.38e-03 | 84 | 59 | 3 | SM00327 | |
| Domain | VWF_A | 3.79e-03 | 99 | 59 | 3 | IPR002035 | |
| Domain | 7TM_GPCR_Srsx | 5.35e-03 | 112 | 59 | 3 | SM01381 | |
| Domain | Ig-like_fold | 6.63e-03 | 706 | 59 | 7 | IPR013783 | |
| Domain | Cyt_P450_E_grp-I | 8.90e-03 | 45 | 59 | 2 | IPR002401 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY | 7.56e-09 | 23 | 44 | 5 | M47537 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 7.56e-09 | 23 | 44 | 5 | M47720 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 1.47e-08 | 26 | 44 | 5 | M47 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY | 1.47e-08 | 26 | 44 | 5 | M47719 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 2.18e-08 | 28 | 44 | 5 | M47655 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 3.15e-08 | 30 | 44 | 5 | M47724 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY | 3.15e-08 | 30 | 44 | 5 | M47718 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 3.22e-06 | 74 | 44 | 5 | M39462 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 3.22e-06 | 74 | 44 | 5 | M16376 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 3.61e-06 | 135 | 44 | 6 | MM14781 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 3.67e-06 | 76 | 44 | 5 | MM14867 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 5.68e-06 | 83 | 44 | 5 | M8728 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 6.03e-06 | 84 | 44 | 5 | M7098 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 6.39e-06 | 85 | 44 | 5 | M16441 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 8.46e-06 | 90 | 44 | 5 | M835 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.36e-05 | 258 | 44 | 7 | MM14572 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 1.56e-05 | 102 | 44 | 5 | M39577 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 1.56e-05 | 102 | 44 | 5 | MM15830 | |
| Pathway | PID_ARF6_TRAFFICKING_PATHWAY | 1.58e-05 | 49 | 44 | 4 | M67 | |
| Pathway | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | 2.65e-05 | 19 | 44 | 3 | MM15113 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 3.56e-05 | 121 | 44 | 5 | M39823 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.59e-05 | 300 | 44 | 7 | M610 | |
| Pathway | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | 3.63e-05 | 21 | 44 | 3 | M878 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 5.17e-05 | 66 | 44 | 4 | M18 | |
| Pathway | PID_LYMPH_ANGIOGENESIS_PATHWAY | 6.22e-05 | 25 | 44 | 3 | M274 | |
| Pathway | WP_PI3KAKT_SIGNALING | 7.79e-05 | 339 | 44 | 7 | M39736 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 1.20e-04 | 31 | 44 | 3 | MM1343 | |
| Pathway | KEGG_HEMATOPOIETIC_CELL_LINEAGE | 1.52e-04 | 87 | 44 | 4 | M6856 | |
| Pathway | PID_CXCR4_PATHWAY | 2.60e-04 | 100 | 44 | 4 | M124 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 3.27e-04 | 302 | 44 | 6 | M39719 | |
| Pathway | BIOCARTA_LYMPHOCYTE_PATHWAY | 3.38e-04 | 9 | 44 | 2 | MM1534 | |
| Pathway | REACTOME_CHL1_INTERACTIONS | 3.38e-04 | 9 | 44 | 2 | M27379 | |
| Pathway | BIOCARTA_EPHA4_PATHWAY | 3.38e-04 | 9 | 44 | 2 | MM1388 | |
| Pathway | BIOCARTA_LYMPHOCYTE_PATHWAY | 3.38e-04 | 9 | 44 | 2 | M22008 | |
| Pathway | WP_FOCAL_ADHESION | 3.70e-04 | 199 | 44 | 5 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 3.70e-04 | 199 | 44 | 5 | M7253 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.18e-04 | 47 | 44 | 3 | MM14925 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 4.91e-04 | 326 | 44 | 6 | MM15917 | |
| Pathway | KEGG_REGULATION_OF_ACTIN_CYTOSKELETON | 5.05e-04 | 213 | 44 | 5 | M18306 | |
| Pathway | BIOCARTA_MONOCYTE_PATHWAY | 5.14e-04 | 11 | 44 | 2 | MM1436 | |
| Pathway | BIOCARTA_MONOCYTE_PATHWAY | 5.14e-04 | 11 | 44 | 2 | M4956 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 5.38e-04 | 121 | 44 | 4 | M872 | |
| Pathway | BIOCARTA_UCALPAIN_PATHWAY | 6.16e-04 | 12 | 44 | 2 | MM1525 | |
| Pathway | WP_11P112_COPY_NUMBER_VARIATION_SYNDROME | 7.01e-04 | 56 | 44 | 3 | M48075 | |
| Pathway | BIOCARTA_LYM_PATHWAY | 8.46e-04 | 14 | 44 | 2 | M1469 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 1.11e-03 | 16 | 44 | 2 | M9450 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.23e-03 | 68 | 44 | 3 | MM14968 | |
| Pathway | BIOCARTA_BCELLSURVIVAL_PATHWAY | 1.26e-03 | 17 | 44 | 2 | MM1353 | |
| Pathway | WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE | 1.26e-03 | 17 | 44 | 2 | M39733 | |
| Pathway | BIOCARTA_LAIR_PATHWAY | 1.26e-03 | 17 | 44 | 2 | M3952 | |
| Pathway | WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4 | 1.41e-03 | 18 | 44 | 2 | M39327 | |
| Pathway | BIOCARTA_MCALPAIN_PATHWAY | 1.57e-03 | 19 | 44 | 2 | MM1434 | |
| Pathway | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | 1.57e-03 | 19 | 44 | 2 | M10959 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.70e-03 | 76 | 44 | 3 | M27219 | |
| Pathway | BIOCARTA_ECM_PATHWAY | 1.93e-03 | 21 | 44 | 2 | MM1390 | |
| Pathway | PID_PRL_SIGNALING_EVENTS_PATHWAY | 2.31e-03 | 23 | 44 | 2 | M11 | |
| Pathway | WP_FOCAL_ADHESION | 2.69e-03 | 187 | 44 | 4 | MM15913 | |
| Pathway | PID_INTEGRIN_A9B1_PATHWAY | 2.73e-03 | 25 | 44 | 2 | M118 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_OVERVIEW | 2.73e-03 | 25 | 44 | 2 | MM15931 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 2.85e-03 | 190 | 44 | 4 | M8240 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY | 2.95e-03 | 26 | 44 | 2 | M39784 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY | 2.95e-03 | 26 | 44 | 2 | MM15892 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_OVERVIEW | 3.18e-03 | 27 | 44 | 2 | M39863 | |
| Pathway | WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING | 3.42e-03 | 28 | 44 | 2 | M39572 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 3.92e-03 | 30 | 44 | 2 | M27216 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 4.45e-03 | 32 | 44 | 2 | MM14924 | |
| Pathway | BIOCARTA_INTEGRIN_PATHWAY | 4.73e-03 | 33 | 44 | 2 | MM1426 | |
| Pathway | PID_INTEGRIN_A4B1_PATHWAY | 4.73e-03 | 33 | 44 | 2 | M277 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 4.73e-03 | 33 | 44 | 2 | M6220 | |
| Pathway | BIOCARTA_MET_PATHWAY | 4.73e-03 | 33 | 44 | 2 | MM1494 | |
| Pathway | PID_IL2_PI3K_PATHWAY | 5.01e-03 | 34 | 44 | 2 | M143 | |
| Pathway | WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING | 5.01e-03 | 34 | 44 | 2 | M39383 | |
| Pathway | PID_ARF6_PATHWAY | 5.31e-03 | 35 | 44 | 2 | M86 | |
| Pathway | WP_OVARIAN_INFERTILITY | 5.31e-03 | 35 | 44 | 2 | MM15948 | |
| Pathway | WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING | 5.61e-03 | 36 | 44 | 2 | M39908 | |
| Pubmed | Estrogen-dependent uterine secretion of osteopontin activates blastocyst adhesion competence. | 5.90e-10 | 23 | 64 | 5 | 23152823 | |
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 1.41e-09 | 27 | 64 | 5 | 31541017 | |
| Pubmed | 5.94e-09 | 3 | 64 | 3 | 30819933 | ||
| Pubmed | Integrin requirement for hippocampal synaptic plasticity and spatial memory. | 1.87e-08 | 16 | 64 | 4 | 12904471 | |
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 23284937 | ||
| Pubmed | The integrin ligand SVEP1 regulates GPCR-mediated vasoconstriction via integrins α9β1 and α4β1. | 2.37e-08 | 4 | 64 | 3 | 35802072 | |
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 27929375 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 22002573 | ||
| Pubmed | 4.94e-08 | 20 | 64 | 4 | 22687584 | ||
| Pubmed | 5.93e-08 | 5 | 64 | 3 | 21060781 | ||
| Pubmed | Involvement of transmembrane domain interactions in signal transduction by alpha/beta integrins. | 1.18e-07 | 6 | 64 | 3 | 14681217 | |
| Pubmed | 1.18e-07 | 6 | 64 | 3 | 3546305 | ||
| Pubmed | Integrin expression patterns during early limb muscle development in the mouse. | 2.07e-07 | 7 | 64 | 3 | 14516674 | |
| Pubmed | The C-type lectin domain of CD62P (P-selectin) functions as an integrin ligand. | 2.07e-07 | 7 | 64 | 3 | 37184585 | |
| Pubmed | Expression of beta 1 integrin complexes on the surface of unfertilized mouse oocyte. | 3.31e-07 | 8 | 64 | 3 | 7691492 | |
| Pubmed | 4.95e-07 | 9 | 64 | 3 | 1693624 | ||
| Pubmed | 1.29e-06 | 12 | 64 | 3 | 19693543 | ||
| Pubmed | 1.68e-06 | 13 | 64 | 3 | 20563599 | ||
| Pubmed | 2.66e-06 | 15 | 64 | 3 | 15366018 | ||
| Pubmed | Genetic nomenclature for loci controlling surface antigens of mouse hemopoietic cells. | 2.85e-06 | 53 | 64 | 4 | 1431091 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 28356532 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 18632734 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 18801913 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 26542396 | ||
| Pubmed | Expression of VLA-4 molecule in PBMC from patients with hemorrhagic fever with renal syndrome. | 3.33e-06 | 2 | 64 | 2 | 21298552 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 20435742 | ||
| Pubmed | An O-Glycosylation of Fibronectin Mediates Hepatic Osteodystrophy Through α4β1 Integrin. | 3.33e-06 | 2 | 64 | 2 | 27427791 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 12844491 | ||
| Pubmed | α9β1 integrin & its ligands as new potential biomarkers in FMF. | 3.33e-06 | 2 | 64 | 2 | 39382510 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 20033667 | ||
| Pubmed | Cloning of ClC-2 chloride channel from murine duodenum and its presence in CFTR knockout mice. | 3.33e-06 | 2 | 64 | 2 | 10524221 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 20531279 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 23160057 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 19608669 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 19796635 | ||
| Pubmed | Glomerular injury is exacerbated in diabetic integrin alpha1-null mice. | 3.33e-06 | 2 | 64 | 2 | 16775606 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 25081983 | ||
| Pubmed | Real-time analysis of very late antigen-4 affinity modulation by shear. | 3.33e-06 | 2 | 64 | 2 | 15226304 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 23812936 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 25367365 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 19850917 | ||
| Pubmed | Bone homing of mesenchymal stem cells by ectopic alpha 4 integrin expression. | 3.33e-06 | 2 | 64 | 2 | 17622670 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 9885280 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 15166232 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 18633440 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 15007059 | ||
| Pubmed | Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis. | 3.33e-06 | 2 | 64 | 2 | 20388801 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 16002725 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 23523785 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 18501656 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 19129508 | ||
| Pubmed | Expression of native and truncated forms of the human integrin alpha 1 subunit. | 3.33e-06 | 2 | 64 | 2 | 8428973 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 14699013 | ||
| Pubmed | α1β1 integrin-mediated adhesion inhibits macrophage exit from a peripheral inflammatory lesion. | 3.33e-06 | 2 | 64 | 2 | 23509351 | |
| Pubmed | Crystal structure of the alpha1beta1 integrin I domain in complex with an antibody Fab fragment. | 3.33e-06 | 2 | 64 | 2 | 12662928 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 18850009 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 17660399 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 9291578 | ||
| Pubmed | The role of VLA4 polymorphisms in multiple sclerosis: an association study. | 3.33e-06 | 2 | 64 | 2 | 17609118 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 22711564 | ||
| Pubmed | Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival. | 3.33e-06 | 2 | 64 | 2 | 34996933 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 8245132 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 18245559 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 18048918 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 38247876 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 31318439 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 24500283 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 20362630 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 19397781 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 21078296 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 24014605 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 12694973 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 21372020 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 15485856 | ||
| Pubmed | Collagen-binding integrin alpha1beta1 regulates intestinal inflammation in experimental colitis. | 3.33e-06 | 2 | 64 | 2 | 12488427 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 15153775 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 15610531 | ||
| Pubmed | Integrin α1β1 participates in chondrocyte transduction of osmotic stress. | 3.33e-06 | 2 | 64 | 2 | 24495803 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 18805957 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 18376404 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 20483780 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 32722648 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 12021063 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 22370635 | ||
| Pubmed | Molecular analysis of a human interferon-inducible gene family. | 3.33e-06 | 2 | 64 | 2 | 1906403 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 19132244 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 18480266 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 21341269 | ||
| Pubmed | Dual activation of CFTR and CLCN2 by lubiprostone in murine nasal epithelia. | 3.33e-06 | 2 | 64 | 2 | 23316067 | |
| Pubmed | Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. | 4.75e-06 | 18 | 64 | 3 | 19686679 | |
| Pubmed | GPAA1 SGMS1 AGPAT1 CCDC126 CPD ITGA1 ITGA4 RETSAT ADAM10 ITGB1 SLC4A2 | 8.51e-06 | 1168 | 64 | 11 | 19946888 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 9.67e-06 | 569 | 64 | 8 | 30639242 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 15731179 | ||
| Pubmed | IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus. | 9.99e-06 | 3 | 64 | 2 | 23720721 | |
| Pubmed | Integrins mediate adherence and migration of T lymphocytes on human peritoneal mesothelial cells. | 9.99e-06 | 3 | 64 | 2 | 18614994 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 16365170 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 21071450 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 12960301 | ||
| Pubmed | TSC2 modulates cell adhesion and migration via integrin-α1β1. | 9.99e-06 | 3 | 64 | 2 | 22923640 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 11776052 | ||
| Interaction | LGALS1 interactions | 6.05e-06 | 332 | 60 | 8 | int:LGALS1 | |
| Interaction | B3GAT1 interactions | 1.52e-05 | 377 | 60 | 8 | int:B3GAT1 | |
| Interaction | SLC10A1 interactions | 3.01e-05 | 121 | 60 | 5 | int:SLC10A1 | |
| Cytoband | Yp11.3 | 2.27e-04 | 16 | 64 | 2 | Yp11.3 | |
| Cytoband | Xp22.3 | 4.75e-04 | 23 | 64 | 2 | Xp22.3 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 6.80e-08 | 18 | 41 | 4 | 1160 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.41e-06 | 394 | 41 | 8 | 471 | |
| GeneFamily | Pseudoautosomal region 1|Solute carriers | 1.46e-03 | 25 | 41 | 2 | 715 | |
| Coexpression | GSE21360_TERTIARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN | 3.55e-06 | 177 | 61 | 6 | M7637 | |
| Coexpression | GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP | 7.17e-06 | 200 | 61 | 6 | M7018 | |
| Coexpression | GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_UP | 2.96e-05 | 257 | 61 | 6 | M41025 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_100 | 1.97e-06 | 73 | 60 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_200 | 3.51e-06 | 146 | 60 | 6 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_100 | 3.95e-06 | 84 | 60 | 5 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_100 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#4_top-relative-expression-ranked_500 | 4.19e-06 | 85 | 60 | 5 | gudmap_developingGonad_e16.5_testes_500_k4 | |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_top-relative-expression-ranked_1000 | MYOF NPHS2 PIEZO2 IFITM3 TMEM176A MDGA2 SMPD1 CPD ITGA1 ITGA4 TMEM26 ITGB1 | 5.20e-06 | 878 | 60 | 12 | gudmap_kidney_adult_RenCorpuscGlomer_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_200 | 7.36e-06 | 166 | 60 | 6 | gudmap_developingGonad_e18.5_testes_200 | |
| CoexpressionAtlas | Myeloid Cells, DC.11cloSer.Salm3.SI, CD45+ MHCII+ Gr1- CD11c-lo CD11b+, Small Intestine, avg-4 | 8.12e-06 | 364 | 60 | 8 | GSM854276_500 | |
| CoexpressionAtlas | Stem Cells, SC.LT34F.BM, Lineage- cKit+ Sca-1+ flk2- CD34-, Bone marrow, avg-3 | 8.29e-06 | 365 | 60 | 8 | GSM791102_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.Salm3.SI, CD45+ MHCII+ Gr1- CD11c-hi CD11b+ CD103- F480+, Small Intestine, avg-4 | 8.79e-06 | 368 | 60 | 8 | GSM854258_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#5_top-relative-expression-ranked_100 | 9.53e-06 | 15 | 60 | 3 | gudmap_developingGonad_e18.5_testes_100_k5 | |
| CoexpressionAtlas | Myeloid Cells, DC.11cloSer.SI, CD45+ MHCII+ CD11c-lo CD11b+, Small Intestine, avg-5 | 1.05e-05 | 377 | 60 | 8 | GSM854280_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.SI, CD45+ MHCII+ CD11c-hi CD11b+ CD103- F4/80+, Small Intestine, avg-7 | 1.13e-05 | 381 | 60 | 8 | GSM854262_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_k-means-cluster#1_top-relative-expression-ranked_100 | 1.70e-05 | 18 | 60 | 3 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_k1_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.SLN, CD11b-FITC CD4-PE CD11c-eFluor780 CD8a-eFluor450 C, Lymph Node, avg-1 | 1.82e-05 | 407 | 60 | 8 | GSM854287_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#1_top-relative-expression-ranked_200 | 1.90e-05 | 56 | 60 | 4 | gudmap_developingGonad_e18.5_testes_200_k1 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.Lv, CD45+ CD11c+ MHC-II + CD11b high CD103-, Liver, avg-3 | 1.95e-05 | 411 | 60 | 8 | GSM538239_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_200 | 2.33e-05 | 59 | 60 | 4 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.50e-05 | 60 | 60 | 4 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.01e-05 | 224 | 60 | 6 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000_k5 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#3_top-relative-expression-ranked_100 | 4.16e-05 | 24 | 60 | 3 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k3_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_200 | 4.42e-05 | 138 | 60 | 5 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#2_top-relative-expression-ranked_100 | 4.69e-05 | 4 | 60 | 2 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k2_100 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480lo.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 5.13e-05 | 72 | 60 | 4 | GSM605859_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 5.97e-05 | 147 | 60 | 5 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_200 | 5.98e-05 | 27 | 60 | 3 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.17e-05 | 148 | 60 | 5 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_100 | 6.35e-05 | 76 | 60 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.II+480lo.PC, F4/80lo MHC II+ CD11c+ CD115+, Peritoneal Cavity, avg-3 | 6.68e-05 | 77 | 60 | 4 | GSM854294_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#3_top-relative-expression-ranked_500 | 6.68e-05 | 28 | 60 | 3 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k3_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_100 | 7.39e-05 | 79 | 60 | 4 | gudmap_developingGonad_e16.5_testes_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.LuLN, MHCII+ CD11c+ CD8- CD11b+ CD103-, Lymph Node, avg-3 | 7.52e-05 | 366 | 60 | 7 | GSM854255_500 | |
| CoexpressionAtlas | JC_iEC_top-relative-expression-ranked_1000_k-means-cluster#5 | 8.05e-05 | 370 | 60 | 7 | JC_iEC_1000_K5 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_200 | 8.54e-05 | 82 | 60 | 4 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_100 | 8.96e-05 | 83 | 60 | 4 | gudmap_developingGonad_e18.5_testes_100 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.39e-05 | 84 | 60 | 4 | gudmap_developingGonad_P2_testes_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_200 | 9.74e-05 | 163 | 60 | 5 | gudmap_developingGonad_e16.5_testes_200 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.PolyIC.Lu, CD45 MHCII CD11c CD103 CD11b, Lung, avg-3 | 1.01e-04 | 384 | 60 | 7 | GSM605820_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.169+11chi.SLN, CD11b+ CD169+ CD11chigh, Lymph Node, avg-2 | 1.03e-04 | 385 | 60 | 7 | GSM854315_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_100 | 1.23e-04 | 90 | 60 | 4 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_k-means-cluster#3_top-relative-expression-ranked_200 | 1.32e-04 | 35 | 60 | 3 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_k3_200 | |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-1 | 1.50e-04 | 409 | 60 | 7 | GSM476663_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.PolyIC.Lu, CD45 MHCII CD11c CD103 CD11b, Lung, avg-3 | 1.50e-04 | 409 | 60 | 7 | GSM605823_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_500 | 1.50e-04 | 409 | 60 | 7 | gudmap_developingGonad_e16.5_testes_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_200 | 1.51e-04 | 179 | 60 | 5 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_100 | 1.56e-04 | 37 | 60 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_100 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-II+.Bl, CD115+ B220- CD43+ Ly6C- MHCIIhi, Blood, avg-2 | 1.59e-04 | 413 | 60 | 7 | GSM605878_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+24-.Lu, MHCII+ CD11c+ CD103- CD11b+ CD24-, Lung, avg-2 | 1.61e-04 | 414 | 60 | 7 | GSM854271_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#5_top-relative-expression-ranked_500 | 1.71e-04 | 98 | 60 | 4 | gudmap_developingGonad_e14.5_ testes_500_k5 | |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-2 | 1.82e-04 | 422 | 60 | 7 | GSM399442_500 | |
| CoexpressionAtlas | Stem Cells, SC.STSL.BM, CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Bone marrow, avg-3 | 1.84e-04 | 423 | 60 | 7 | GSM399454_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.Lu, CD11chi CD11b low CD103+ MHCII+ SiglecF-, Lung, avg-3 | 1.87e-04 | 424 | 60 | 7 | GSM538231_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.II+480lo.PC, F4/80lo MHC II+ CD11c+ CD115+, Peritoneal Cavity, avg-3 | 1.87e-04 | 424 | 60 | 7 | GSM854294_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480lo.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 1.92e-04 | 426 | 60 | 7 | GSM605859_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_500 | 2.04e-04 | 430 | 60 | 7 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_k-means-cluster#2_top-relative-expression-ranked_500 | 2.12e-04 | 41 | 60 | 3 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_k2_500 | |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_top-relative-expression-ranked_500 | 2.28e-04 | 438 | 60 | 7 | gudmap_kidney_adult_RenCorpuscGlomer_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 2.31e-04 | 439 | 60 | 7 | GSM777059_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 2.69e-04 | 450 | 60 | 7 | GSM777063_500 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 2.80e-04 | 453 | 60 | 7 | GSM777067_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 2.87e-04 | 455 | 60 | 7 | GSM777055_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 2.91e-04 | 456 | 60 | 7 | GSM777032_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 3.03e-04 | 459 | 60 | 7 | GSM777037_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.26e-04 | 116 | 60 | 4 | gudmap_developingGonad_e18.5_testes_1000_k5 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 3.32e-04 | 466 | 60 | 7 | GSM777050_500 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | MYOF PLLP CLCN2 IFITM3 PCNX4 VANGL1 SMPD1 IFITM2 NIPA1 ITGA9 SLC4A2 | 3.40e-04 | 1153 | 60 | 11 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#1_top-relative-expression-ranked_500 | 3.59e-04 | 119 | 60 | 4 | gudmap_developingGonad_P2_testes_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.07e-04 | 123 | 60 | 4 | gudmap_developingGonad_e16.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.07e-04 | 123 | 60 | 4 | gudmap_developingGonad_e16.5_testes_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#5_top-relative-expression-ranked_500 | 4.73e-04 | 128 | 60 | 4 | gudmap_developingGonad_e18.5_testes_500_k5 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 4.97e-04 | 356 | 60 | 6 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 5.02e-04 | 130 | 60 | 4 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 5.35e-04 | 361 | 60 | 6 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | gudmap_RNAseq_p2_CD2APMEISWT_2500_K4 | 5.59e-04 | 842 | 60 | 9 | gudmap_RNAseq_p2_CD2APMEISWT_2500_K4 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | 5.59e-04 | 364 | 60 | 6 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 | |
| CoexpressionAtlas | JC_iEC_top-relative-expression-ranked_2500_k-means-cluster#1 | 5.78e-04 | 672 | 60 | 8 | JC_iEC_2500_K1 | |
| CoexpressionAtlas | gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K1 | 5.98e-04 | 850 | 60 | 9 | gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K1 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 6.35e-04 | 373 | 60 | 6 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_1000 | 7.18e-04 | 872 | 60 | 9 | gudmap_kidney_adult_Mesangium_Meis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#5_top-relative-expression-ranked_200 | 7.20e-04 | 62 | 60 | 3 | gudmap_developingGonad_e16.5_testes_200_k5 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-IIint.Bl, CD115+ B220- CD43- Ly6C- MHCIIint, Blood, avg-5 | 9.14e-04 | 400 | 60 | 6 | GSM605886_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 9.24e-04 | 153 | 60 | 4 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | Myeloid Cells, MF.BM, B220neg CD3neg Ly-6C/Glo CD115int F4/80+, Bone marrow, avg-3 | 9.25e-04 | 401 | 60 | 6 | GSM854317_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.Lu, MHCII+ CD11c+ CD103+ CD11b, Lung, avg-2 | 9.37e-04 | 402 | 60 | 6 | GSM854241_500 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-II-.Bl, CD115+ B220- CD43- Ly6C- MHCII-, Blood, avg-3 | 9.37e-04 | 402 | 60 | 6 | GSM605883_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_100 | 9.43e-04 | 68 | 60 | 3 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+24+.Lu, MHCII+ CD11c+ CD103- CD11b+ CD24+, Lung, avg-2 | 9.62e-04 | 404 | 60 | 6 | GSM854269_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+F4/80lo.Kd, CD45+ CD11c+ I-A/I-E+ CD11b+ F4/80lo, Kidney, avg-3 | 9.86e-04 | 406 | 60 | 6 | GSM854273_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 9.93e-04 | 156 | 60 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_500 | 1.01e-03 | 408 | 60 | 6 | gudmap_developingGonad_P2_testes_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | 1.01e-03 | 408 | 60 | 6 | gudmap_kidney_adult_RenalCapsule_500 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-II-.BM, B220neg CD3neg CD115+ Ly-6C/Glo CD43+, Bone marrow, avg-3 | 1.02e-03 | 409 | 60 | 6 | GSM854332_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_100 | 1.04e-03 | 17 | 60 | 2 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k1_100 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.04e-03 | 158 | 60 | 4 | gudmap_developingGonad_e12.5_testes_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_500 | 1.05e-03 | 411 | 60 | 6 | gudmap_developingGonad_e14.5_ testes_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_500 | 1.06e-03 | 412 | 60 | 6 | gudmap_developingGonad_e18.5_testes_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_200 | 1.07e-03 | 159 | 60 | 4 | gudmap_developingGonad_e14.5_ testes_200 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-II+.Bl, CD115+ B220- CD43+ Ly6C- MHCIIhi, Blood, avg-2 | 1.07e-03 | 71 | 60 | 3 | GSM605878_100 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_200 | 1.12e-03 | 161 | 60 | 4 | gudmap_developingGonad_P2_testes_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_100 | 1.16e-03 | 73 | 60 | 3 | gudmap_developingGonad_e14.5_ testes_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+F4/80lo.Kd, CD45+ CD11c+ I-A/I-E+ CD11b+ F4/80lo, Kidney, avg-3 | 1.16e-03 | 73 | 60 | 3 | GSM854273_100 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.71e-09 | 184 | 64 | 7 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-07 | 159 | 64 | 6 | 323cb4a2416d2e6bff0a3f225d2edeae9ab7dc76 | |
| ToppCell | (3)_MNP-(3)_Macrophage_MARCOneg|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.73e-07 | 195 | 64 | 6 | e4b5e4b8832669fb4d1661ecd828b81e621d35c4 | |
| ToppCell | COVID-19_Severe-PLT_0|World / Disease Group and Platelet Clusters | 4.08e-07 | 198 | 64 | 6 | d508d69d8de233573aee14f17dd8ef054654aa54 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.08e-07 | 198 | 64 | 6 | 94e2567f057b2c455a9656b121321a28e7cb1d2b | |
| ToppCell | Lymphoid-Lymphoid-NK_cells|Lymphoid / shred on cell class and cell subclass (v4) | 2.35e-06 | 148 | 64 | 5 | d51a4b654a88d58dcdf29c2bc362c0cc1c40723a | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-06 | 156 | 64 | 5 | 2ba838bc864c2c1767bcab7bb4d790af96b91387 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-Cilia-bearing_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.88e-06 | 164 | 64 | 5 | 346e1530b4bf30adbcb2f7d64fdfb4cd8df69d7f | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.00e-06 | 165 | 64 | 5 | 479962ce1c3d6636ae62b6709635299748653801 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.12e-06 | 166 | 64 | 5 | 91eeb48680dd07ae4115afacdc0a8f6fa18885e5 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.12e-06 | 166 | 64 | 5 | b3d9b61847c6c96b8cb28b8a6aeda52f43c706ab | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-06 | 168 | 64 | 5 | 2c996d09b6a8ccd3c708146eca310b02eafff425 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.49e-06 | 169 | 64 | 5 | b059304543876f514d5c7214f1f0a2da00f10a67 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-non-classical_monocyte|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.49e-06 | 169 | 64 | 5 | 945f737984c4de70a4e9c214053b005358053dd5 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-non-classical_monocyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.76e-06 | 171 | 64 | 5 | 00739085fdbc4d64c9faacba2c2adeab580dd2b1 | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-06 | 171 | 64 | 5 | 35acc5c3e36bc605603c0d45375f2cf3c3e9d4cd | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.89e-06 | 172 | 64 | 5 | 5f58ff6cac32546d07b2a49ed250b6c7aa417188 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-06 | 172 | 64 | 5 | 66823536288c7009ce01b5177794a3e874e94570 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.47e-06 | 176 | 64 | 5 | 0923b01137d6f9956ca815b41102c81e82624065 | |
| ToppCell | metastatic_Brain-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 5.47e-06 | 176 | 64 | 5 | 9c1f255de3082b3da4bef2a9bdff710cfd48261f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.11e-06 | 180 | 64 | 5 | ea7a1ccf0dd3bb5af5df87501f873e7339a824b3 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic-maDC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.62e-06 | 183 | 64 | 5 | e01dacb08a9c36cf09c0b6764ce032a7232d4cdc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Mesenchymal-Mes-Pericyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.97e-06 | 185 | 64 | 5 | 0e26a71fea526ebfe3b2d1c8d0d6d9b70282bbe9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Mesenchymal-Mes-Pericyte-Peri_L1-6_MUSTN1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.97e-06 | 185 | 64 | 5 | b3320b794b22e654a33f28b575c9f00023baf5f0 | |
| ToppCell | normal_Lung-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 7.16e-06 | 186 | 64 | 5 | 00ad1239b952119b3fd2e6af8f034cba3488f9c1 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-06 | 188 | 64 | 5 | da862ea3c74f42d0dbae38b09211a45c593d477e | |
| ToppCell | facs-Pancreas-Endocrine-3m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-06 | 188 | 64 | 5 | b82a7667ef74a05e8bc744f6c090a7cc7b8efe32 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-06 | 188 | 64 | 5 | 19672d284fe89c9c3c7697514ca1f659329c34f4 | |
| ToppCell | Substantia_nigra-Endothelial|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.74e-06 | 189 | 64 | 5 | bef8234bd9c4d6e3cdef0791d8066b39ba56ebba | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.94e-06 | 190 | 64 | 5 | 2ff4b50b864a35f22c558d7d585cd2b54612b50c | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.94e-06 | 190 | 64 | 5 | 106862ef44fcaa0971c3ba0147d13eb08015ca77 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-Migratory_DCs_L.1.2.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.94e-06 | 190 | 64 | 5 | 5175bf022d55a52988014abe7cece326a8406a38 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.94e-06 | 190 | 64 | 5 | 29e60b9b1c86b44550619c01306b8b1bb2e340dc | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.35e-06 | 192 | 64 | 5 | 448b71c965e1b7addc6bccbcd6047cefda3d5b5a | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.56e-06 | 193 | 64 | 5 | 7426a30ed01e5c8376b3e0ebe0f1057cfee88340 | |
| ToppCell | 10x5'-blood|World / Manually curated celltypes from each tissue | 8.56e-06 | 193 | 64 | 5 | 359d4242a7e5e51a3eaf6fe51bc1c653a402b054 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_10|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.56e-06 | 193 | 64 | 5 | a2194012dfa0174c6160900625c44e0fd04c50e7 | |
| ToppCell | 356C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 8.78e-06 | 194 | 64 | 5 | 11ff53a748160570d2908ea9eb9779c038e5b676 | |
| ToppCell | (0)_Myeloid-(00)_Monocyte-(001)_CD16+_Monocyte|(00)_Monocyte / immune cells in Peripheral Blood (logTPM normalization) | 8.78e-06 | 194 | 64 | 5 | 89cb262e04d7105012e957e0add44c73de6c1ed0 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.78e-06 | 194 | 64 | 5 | 2c78e754cac848fd47172f94e392749eb0ab50d4 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.78e-06 | 194 | 64 | 5 | 92a8e6e3e3f6fd9dacb723b58e7a8b63473e403e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.78e-06 | 194 | 64 | 5 | 78dcb9d48259afabe73b41c5508a73a8d62339a4 | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 8.78e-06 | 194 | 64 | 5 | 58046894446cb250814252a23f60fdd59c114d77 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.00e-06 | 195 | 64 | 5 | 4008fa86b5166087a4b20f89ae07e1dfc87c855d | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.00e-06 | 195 | 64 | 5 | e87b11e3242fdbed2e7f383e6876ec375af32bd4 | |
| ToppCell | Cerebellum-Endothelial|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 9.00e-06 | 195 | 64 | 5 | 2192fd9b4682054776f0716933aed5a4a9412657 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.00e-06 | 195 | 64 | 5 | 9168267a799bbd4111b1227754ab8173ac1a4714 | |
| ToppCell | 343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 9.00e-06 | 195 | 64 | 5 | 67b05a0cd2ca9924eca81a92cc6330eecb9d963c | |
| ToppCell | 10x5'-blood-Myeloid_Monocytic-Nonclassical_monocytes|blood / Manually curated celltypes from each tissue | 9.00e-06 | 195 | 64 | 5 | 88d65c7c3a28922c125bd9f7c403a55d7d4d83a9 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.23e-06 | 196 | 64 | 5 | 65d882c6e7f6d5778b8a5fd4fdaf012e1b9f6100 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 9.23e-06 | 196 | 64 | 5 | e8c4eeb4b6c6d9bccca2adb942d4cfbaab39636c | |
| ToppCell | (5)_Dendritic_cell-(53)_Lymphoid_DC|(5)_Dendritic_cell / shred on Cell_type and subtype | 9.69e-06 | 198 | 64 | 5 | 548da5fa86f9756c503ed77bcdde55bc4d1a2726 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.69e-06 | 198 | 64 | 5 | 579a22199643440b98e381147779ced630d4ed66 | |
| ToppCell | Non-neuronal-Postmitotic-Mural-Mural|World / Primary Cells by Cluster | 9.69e-06 | 198 | 64 | 5 | 9fc1035ea447a4551a66944c869c4671e17cec61 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.69e-06 | 198 | 64 | 5 | f3a12a7e23bb4ff6e82fee675dbc090d99587f69 | |
| ToppCell | Non-neuronal-Postmitotic-Mural|World / Primary Cells by Cluster | 9.69e-06 | 198 | 64 | 5 | dd38840a96171f58da243daa22b013e15a81db4a | |
| ToppCell | Non-neuronal-Postmitotic-Mural-Mural-18|World / Primary Cells by Cluster | 9.69e-06 | 198 | 64 | 5 | 21efb7bcd24f24d20791b34e75d6f9d46a129481 | |
| ToppCell | mLN-(0)_NK_cell-(00)_NK|mLN / shred on region, Cell_type, and subtype | 9.93e-06 | 199 | 64 | 5 | 59d8e4f57580c7273308c32e5308fc1d704b1f6d | |
| ToppCell | mLN-NK_cell-NK|mLN / Region, Cell class and subclass | 9.93e-06 | 199 | 64 | 5 | cc9836b8d18edabe8849a3e948b84d954ef68c48 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-MoAM-3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 9.93e-06 | 199 | 64 | 5 | 1ce46d9edabb3252f940a5143dd3f2404422d185 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.93e-06 | 199 | 64 | 5 | c4fc638a8dad3a9b77634e8912a9326c8a2f11f5 | |
| ToppCell | mLN-NK_cell|mLN / Region, Cell class and subclass | 9.93e-06 | 199 | 64 | 5 | dcc1d9a3f6f0e64f111d18386bfe5b154e9d5bbe | |
| ToppCell | BAL-Severe-cDC_10|Severe / Compartment, Disease Groups and Clusters | 9.93e-06 | 199 | 64 | 5 | 54bdadd04abaf8caa948b0177c037bc089ca07e6 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.93e-06 | 199 | 64 | 5 | 97af159fa3a5533ec3d45331fb80c6da8a715aa5 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Erythrophagocytic_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 9.93e-06 | 199 | 64 | 5 | 78db2e3b85356ed2f08794e5a97c16a220f8a076 | |
| ToppCell | mLN-(0)_NK_cell|mLN / shred on region, Cell_type, and subtype | 9.93e-06 | 199 | 64 | 5 | 05f5ae4c049f242131a7f59bcce4b18ed52f11be | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.93e-06 | 199 | 64 | 5 | eeb7d370d4dfacf705306c72ccc4919ddefacff1 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_activated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.93e-06 | 199 | 64 | 5 | f4ab29f99ce45a3044d2e9f356dc24d3c5e7121f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.93e-06 | 199 | 64 | 5 | 697a9a58c0cdb77222700d029873355d37f6ab28 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 9.93e-06 | 199 | 64 | 5 | c051cc3e42cfa2ec09fd8dae1172af350bb2dfcb | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.93e-06 | 199 | 64 | 5 | 6783d571d28eac891fcc70380f176b53f35c88ba | |
| ToppCell | COVID-19-kidney-Glomerular_EC|kidney / Disease (COVID-19 only), tissue and cell type | 9.93e-06 | 199 | 64 | 5 | fffd2f9042b55531dac4e5b463b5cee80402e7bb | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.02e-05 | 200 | 64 | 5 | 501cd2b4e55444fc5fdd93ebbcfc0616442b110b | |
| ToppCell | mLN-Macrophage|mLN / Region, Cell class and subclass | 1.02e-05 | 200 | 64 | 5 | 68d709afd226241e002dae6d6820bccd1cfd87a1 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.02e-05 | 200 | 64 | 5 | cf883ba5dbe6350b93142d625a52b25ff2a8bb63 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 200 | 64 | 5 | d9dab2aed11e45c60d11ff0c5af1f2fbb9cb45d8 | |
| ToppCell | mLN-(6)_Macrophage|mLN / shred on region, Cell_type, and subtype | 1.02e-05 | 200 | 64 | 5 | 6dcba82a7d322102bae205543086e84c7655b3e0 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 200 | 64 | 5 | 33b7af6c50e65dc1bdf429572574ed072f8bc29f | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_1(EFTUD1P1)---L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.02e-05 | 200 | 64 | 5 | 046a3a4d7e4d84ee4252a695ffd4a6aee8b77070 | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_1(EFTUD1P1)-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.02e-05 | 200 | 64 | 5 | 893cc7f6b9794da90aa0c9d721b8647dc97201cd | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_1(EFTUD1P1)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.02e-05 | 200 | 64 | 5 | 3d677f13e429abc805a52ec2b8f36c703f511569 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.02e-05 | 200 | 64 | 5 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_1(EFTUD1P1)--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.02e-05 | 200 | 64 | 5 | 12518f4a8d01fc66b72878cdf0ba124b37cff3d8 | |
| ToppCell | Myeloid-Myeloid-C_(Cd16+_Monocyte)|Myeloid / shred on cell class and cell subclass (v4) | 2.45e-05 | 117 | 64 | 4 | d1936e76a935216783a73ab414e4147fa48e68eb | |
| ToppCell | Myeloid-Myeloid-C_(Monocyte)|Myeloid / shred on cell class and cell subclass (v4) | 5.97e-05 | 147 | 64 | 4 | d7cfec8ec1b4854d783a1bb07b4f8d2b2fd22893 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-05 | 147 | 64 | 4 | 9d7e965fe61bd7b31e09c4b2129a5a98c36f4811 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-05 | 147 | 64 | 4 | 38552953ff65a0fc20bee6ef57dc5885306ad18b | |
| ToppCell | facs-Brain_Myeloid-Cerebellum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.62e-05 | 151 | 64 | 4 | 3105b8c0c401faa92e1ab8223d435b21ed45c5b7 | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-05 | 153 | 64 | 4 | 0ef7c45cdd854c79e527006034029767f8e108b2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.15e-05 | 154 | 64 | 4 | 9316732964a819a8e935a952faa3823109f90b77 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.51e-05 | 156 | 64 | 4 | 28c4fb4d2c6c47696c3a6722998f9da5a8923323 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.70e-05 | 157 | 64 | 4 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-05 | 158 | 64 | 4 | d3446fc98eff09c3626b47a2c90d07cd985378b5 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-24m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-05 | 158 | 64 | 4 | f41ee21e5888359d817be1e3a902c132cb68e350 | |
| ToppCell | droplet-Fat-Scat-21m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-05 | 158 | 64 | 4 | c8df636412a08c570f235c34d4cff46924a9b11d | |
| ToppCell | droplet-Fat-Scat-21m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-05 | 158 | 64 | 4 | 718eafcf8a171bb69b402dc9d69564c3521a62a9 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-05 | 158 | 64 | 4 | df614450e10629dc9115d7365397663e82f9e48f | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-24m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-05 | 158 | 64 | 4 | d689feb7f612aef170da76fcf14abf2dd589082b | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-24m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-05 | 158 | 64 | 4 | 829ff3df46f173f2ff1c435e9bce35425e603b42 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.29e-05 | 160 | 64 | 4 | 1f7acdc8b08152d5817fc53bbf47b4a22d9c91b5 | |
| Drug | oxypertine | 1.57e-07 | 49 | 58 | 5 | CID000004640 | |
| Drug | indole-3-acetyl-l-valine | 6.61e-07 | 65 | 58 | 5 | CID000446641 | |
| Drug | N-methylformamide | 7.14e-07 | 66 | 58 | 5 | CID000031254 | |
| Drug | MP-B | 2.38e-06 | 84 | 58 | 5 | CID000016827 | |
| Drug | Chlorides | 3.95e-06 | 42 | 58 | 4 | ctd:D002712 | |
| Drug | 4,4'-diaminostilbene | 6.38e-06 | 2 | 58 | 2 | CID000092134 | |
| Drug | Rgds Peptide | 7.49e-06 | 106 | 58 | 5 | CID000107775 | |
| Drug | 5-nitro-2-(3-phenylpropylamino)benzoic acid | 9.37e-06 | 52 | 58 | 4 | CID000004549 | |
| Drug | AC1L9LQQ | 1.35e-05 | 57 | 58 | 4 | CID000448224 | |
| Drug | nitrogen sulfide | 1.91e-05 | 3 | 58 | 2 | CID005463441 | |
| Drug | AC1NDU26 | 2.33e-05 | 22 | 58 | 3 | CID004631606 | |
| Drug | PVLA | 2.33e-05 | 22 | 58 | 3 | CID000126094 | |
| Drug | trypanothione disulfide | 2.89e-05 | 140 | 58 | 5 | CID000115098 | |
| Drug | Rgd Peptide | 3.22e-05 | 239 | 58 | 6 | CID000104802 | |
| Drug | pyrachlostrobin | DDR1 MYOF ANTXR2 IFITM3 VANGL1 IFITM2 ITGA1 RETSAT ITGB1 SLC4A2 | 3.45e-05 | 811 | 58 | 10 | ctd:C513428 |
| Drug | Q-MS | 3.91e-05 | 26 | 58 | 3 | CID000151506 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; HL60; HT_HG-U133A | 5.46e-05 | 160 | 58 | 5 | 6133_DN | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 5.63e-05 | 161 | 58 | 5 | 3556_DN | |
| Drug | 2-(2,6-dioxopiperidin-3-yl)phthalimidine | 6.35e-05 | 5 | 58 | 2 | ctd:C001079 | |
| Drug | 2-methoxy-N-(3-methyl-2-oxo-1,2,3,4-tetrahydroquinazolin-6-yl)benzenesulfonamide | 6.70e-05 | 31 | 58 | 3 | ctd:C577942 | |
| Drug | AC1MM84Q | 8.88e-05 | 34 | 58 | 3 | CID003256860 | |
| Drug | Deptropine citrate [2169-75-7]; Down 200; 7.6uM; HL60; HT_HG-U133A | 1.23e-04 | 190 | 58 | 5 | 3144_DN | |
| Disease | Astrocytosis | 5.60e-06 | 17 | 61 | 3 | C3887640 | |
| Disease | Gliosis | 5.60e-06 | 17 | 61 | 3 | C0017639 | |
| Disease | Choledochal Cyst, Type II | 4.19e-05 | 5 | 61 | 2 | C1257796 | |
| Disease | Choledochal Cyst, Type III | 4.19e-05 | 5 | 61 | 2 | C1257797 | |
| Disease | Choledochal Cyst, Type IV | 4.19e-05 | 5 | 61 | 2 | C1257798 | |
| Disease | Choledochal Cyst, Type V | 4.19e-05 | 5 | 61 | 2 | C1257799 | |
| Disease | Choledochal Cyst, Type I | 4.19e-05 | 5 | 61 | 2 | C0009439 | |
| Disease | Choledochal Cyst | 4.19e-05 | 5 | 61 | 2 | C0008340 | |
| Disease | pancreatic cancer (is_implicated_in) | 8.69e-05 | 112 | 61 | 4 | DOID:1793 (is_implicated_in) | |
| Disease | Male sterility | 1.36e-04 | 48 | 61 | 3 | C0917731 | |
| Disease | Male infertility | 1.36e-04 | 48 | 61 | 3 | C0021364 | |
| Disease | Subfertility, Male | 1.36e-04 | 48 | 61 | 3 | C0848676 | |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 1.50e-04 | 9 | 61 | 2 | C0085548 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 1.50e-04 | 9 | 61 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | Ashkenazi Jewish disorders | 2.28e-04 | 11 | 61 | 2 | cv:CN118946 | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 2.28e-04 | 11 | 61 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | autism spectrum disorder symptom | 1.03e-03 | 23 | 61 | 2 | EFO_0005426 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MAFKLLILLIGTWAL | 156 | Q8TAA9 | |
| IGFWLVFLALLMVAL | 796 | P04920 | |
| LQVALLMGLIWELLQ | 206 | P13569 | |
| MVLLRVLILLLSWAA | 1 | O14672 | |
| LWMGLVLALALALAL | 31 | P17405 | |
| IILLLLLIIALMLWR | 426 | Q08345 | |
| KMFLILNLLFLLSWL | 276 | Q15760 | |
| LVLLLLLGIGLMWWF | 326 | P58335 | |
| MALLLLLFLGLLGLW | 1 | Q8TAV3 | |
| WQALQLLLAILLTLM | 6 | Q9H112 | |
| WMALVLLGLFLLLLL | 146 | Q16671 | |
| RWIILGAFILLVLMG | 226 | Q8TD07 | |
| KMLLIVALLFILSWL | 376 | Q9Y5X5 | |
| MLLQLVLGLLVWALI | 41 | Q9Y342 | |
| VLIGLALLLIWKLLM | 741 | P05556 | |
| FIGLGLSLMLLKWIV | 76 | P56975 | |
| FLRVLIWLINILAIM | 361 | P22888 | |
| MKLVNIWLLLLVVLL | 1 | Q14703 | |
| LLLVLGLKALELWMQ | 381 | O43292 | |
| NIWALILGIFMTILL | 106 | Q01629 | |
| LNIWALILGILMTIL | 106 | Q01628 | |
| MELGLSWIFLLAILK | 1 | P01782 | |
| VGYGLMILLIILWIL | 391 | Q63HM2 | |
| MRLLAQLLGLLMLWV | 1 | A0A075B6R9 | |
| CEWLLVLISLLFIIM | 101 | Q9NP85 | |
| TLLILLVWAIAIFMG | 146 | Q9UBY5 | |
| TLSILVLMGGLIWFL | 1676 | O60449 | |
| LLMVSLLLLSLWKLW | 241 | Q9HC73 | |
| AGLLLLMLLILALWK | 1151 | P56199 | |
| MDLLYGLVWLLTVLL | 1 | Q7Z553 | |
| ILAYLGFLWMLLLVA | 1951 | Q7Z442 | |
| MALVLILQLLTLWPL | 1 | Q8IYS5 | |
| ILIFLLLAVLLWKMG | 991 | Q13797 | |
| MVLLWLTLLLIALPC | 1 | P26951 | |
| MLGVLELLLLGAAWL | 1 | P23435 | |
| GLLVFLLIIAVLMWL | 371 | Q8WUS8 | |
| LLLLVFGLIWGLMLL | 16 | Q96EE4 | |
| LNIWALILGILMTIL | 106 | C9JQL5 | |
| MWELVALLLLTLAYL | 1 | P05093 | |
| WRLGRLLLLMCLLLL | 11 | O75976 | |
| LLGLIVLLLISYVMW | 986 | P13612 | |
| MRLLAQLLGLLMLWV | 1 | A0A0C4DH68 | |
| CIVLLMLLLLIFWIA | 166 | Q7RTP0 | |
| MWLPLVLLLAVLLLA | 1 | Q6NUM9 | |
| LVVSRIGLLWVMLFL | 51 | P59542 | |
| TFLLMLIIGRWLLPI | 151 | Q6ZUK4 | |
| LQAMLLGVWILLLLA | 191 | Q96HP8 | |
| KLLLMLTFILIFWII | 21 | Q96DL1 | |
| ILVAWMVIALILFLL | 56 | Q96QK8 | |
| MVLCFPLLLLLLVLW | 1 | Q93091 | |
| GGLLLLTILVLAMWK | 1006 | P08514 | |
| LIALKWLLGRIFALL | 436 | Q8TDI8 | |
| WIFLVLLGLLMALVS | 91 | P51788 | |
| LVWVVMEVLALLLGL | 176 | O95070 | |
| MISLRVLLVILWLQL | 1 | A0A0B4J245 | |
| GAWMLLLLLFLLLLF | 6 | Q99943 | |
| ITLLLPILIFLWAML | 1941 | Q9H5I5 | |
| GMILVGLWLIQWLLL | 191 | Q86VZ5 | |
| LLIFLLLVILAMGLW | 241 | Q96A28 | |
| GIIFLVLILDLNMWK | 306 | Q9H0C3 | |
| LPVMWLFILLSLALI | 56 | P0DMS9 | |
| METLLGLLILWLQLQ | 1 | A0A0B4J279 | |
| WGLEGILYLLLALML | 106 | Q8WW34 | |
| MILNWKLLGILVLCL | 1 | Q9UIG4 | |
| WVIIGLLFLLILLLF | 2026 | Q9NZM1 |